Cold Plasma Therapy in Chronic Wounds-A Multicenter, Randomized Controlled Clinical Trial (Plasma on Chronic Wounds for Epidermal Regeneration Study): Preliminary Results.

chronic wounds cold plasma diabetes mellitus epidermal regeneration health economics plasma plasma therapy wound wound-healing disorder

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
04 Aug 2023
Historique:
received: 13 06 2023
revised: 27 07 2023
accepted: 02 08 2023
medline: 12 8 2023
pubmed: 12 8 2023
entrez: 12 8 2023
Statut: epublish

Résumé

Chronic wounds (CWs) pose a significant health challenge in clinical practice. Standard wound therapy (SWT) is currently considered the gold standard. However, recent evidence suggests that cold plasma therapy (CPT) holds promise for improving CWs. In light of this, the POWER study was conducted as a multicenter, randomized clinical trial to investigate the effect of large-area plasma application compared with SWT in patients with chronic, non-healing arterial or venous wounds on the lower leg. To analyze the interim results, we employed a comprehensive range of statistical tests, including both parametric and non-parametric methods, as well as GLS model regression and an ordinal mixed model. Our findings clearly demonstrate that CPT therapy significantly accelerates wound closure compared with SWT. In fact, complete wound closure was exclusively observed in the CPT group during the intervention period. Additionally, the CPT group required significantly less antibiotic therapy (4%) compared with the SWT group (23%). Furthermore, CPT led to a significant reduction in wound pain and improved quality of life compared with SWT. In conclusion, the study highlights that the combination of CPT and SWT surpasses monotherapy with SWT alone.

Identifiants

pubmed: 37568525
pii: jcm12155121
doi: 10.3390/jcm12155121
pmc: PMC10419810
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Bundesministerium für Bildung und Forschung (BMBF)
ID : 13GW0448B

Références

Arch Dermatol Res (1975). 1977 Jul 21;259(1):1-10
pubmed: 71020
J Eur Acad Dermatol Venereol. 2015 Jan;29(1):148-55
pubmed: 24666170
Eur J Epidemiol. 2016 Apr;31(4):337-50
pubmed: 27209009
Surg Clin North Am. 2020 Aug;100(4):681-693
pubmed: 32681869
Antibiotics (Basel). 2021 Feb 20;10(2):
pubmed: 33672690
Immunol Allergy Clin North Am. 2011 Feb;31(1):81-93
pubmed: 21094925
J Biophotonics. 2015 May;8(5):382-91
pubmed: 24659472
Clujul Med. 2016;89(3):365-70
pubmed: 27547055
Wound Repair Regen. 2019 Jan;27(1):114-125
pubmed: 30362646
Int J Mol Sci. 2016 Dec 11;17(12):
pubmed: 27973441
Med Gas Res. 2013 Oct 01;3(1):21
pubmed: 24083477
Pain Pract. 2003 Dec;3(4):310-6
pubmed: 17166126
Int J Low Extrem Wounds. 2023 Mar;22(1):77-84
pubmed: 33856260
Br J Dermatol. 2012 Aug;167(2):404-10
pubmed: 22385038
Int Wound J. 2020 Oct;17(5):1128-1134
pubmed: 32815303
J Gen Virol. 2020 Feb;101(2):208-215
pubmed: 31961788
Ann Epidemiol. 2019 Jan;29:8-15
pubmed: 30497932
Int Wound J. 2019 Feb;16(1):103-111
pubmed: 30311743
Int J Mol Sci. 2020 Apr 22;21(8):
pubmed: 32331263
Adv Skin Wound Care. 2018 Mar;31(3):102-108
pubmed: 29438143
Inflammation. 2022 Dec;45(6):2433-2448
pubmed: 35713788
Int Wound J. 2015 Dec;12(6):630-5
pubmed: 24164755
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Int J Mol Sci. 2019 Jun 26;20(13):
pubmed: 31248061
Sci Rep. 2022 Mar 7;12(1):3645
pubmed: 35256635
Int Wound J. 2008 Jun;5(2):159-71
pubmed: 18494622
J Dtsch Dermatol Ges. 2018 Jan;16(1):7-13
pubmed: 29211323
Physiol Meas. 2006 Aug;27(8):R49-62
pubmed: 16772664
Arch Biochem Biophys. 2016 Sep 1;605:76-85
pubmed: 27046340
J Biol Chem. 1978 Mar 10;253(5):1336-7
pubmed: 342524
Adv Ther. 2016 Jun;33(6):894-909
pubmed: 27142848
J Wound Care. 2017 Dec 2;26(12):727-732
pubmed: 29244967
J Dermatol Sci. 2018 Feb;89(2):181-190
pubmed: 29191392
Br J Dermatol. 2010 Jul;163(1):78-82
pubmed: 20222930
J Clin Epidemiol. 1998 Nov;51(11):1171-8
pubmed: 9817135
Appl Microbiol Biotechnol. 2021 Mar;105(5):2057-2070
pubmed: 33587156
BMJ. 1996 May 4;312(7039):1153
pubmed: 8620137
J Wound Care. 2018 May 2;27(5):273-277
pubmed: 29738295
Comput Math Methods Med. 2022 Oct 10;2022:5798857
pubmed: 36262869
J Biophotonics. 2021 Mar;14(3):e202000415
pubmed: 33231354
Ther Adv Drug Saf. 2014 Dec;5(6):229-41
pubmed: 25436105
JAMA Netw Open. 2020 Jul 1;3(7):e2010411
pubmed: 32672829

Auteurs

Nessr Abu Rached (N)

Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Gudrunstr. 56, 44791 Bochum, Germany.

Susanne Kley (S)

Scientific Institute for Health Economics and Health Research, Markt 9, 04109 Leipzig, Germany.

Martin Storck (M)

Municipal Hospital Karlsruhe gGmbH, Moltkestraße 90, 76133 Karlsruhe, Germany.

Thomas Meyer (T)

Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Gudrunstr. 56, 44791 Bochum, Germany.

Markus Stücker (M)

Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Gudrunstr. 56, 44791 Bochum, Germany.

Classifications MeSH